Update All
   ✏️  Posts: 17,411
 ✏️  Posts: 17,411

 1. COVID19 Deaths during Corona pandemic largely among overweight people (dutch)
2023-09-29 06:41:51 EST Source
 2. COVID19 New-Onset Arthritis Following COVID-19 Vaccination: A Systematic Review of Case Reports
2023-09-29 06:17:18 EST Source
 3. COVID19 DNA in mRNA vaccines
2023-09-28 02:10:55 EST Source
 4. COVID19 Duration of SARS-CoV-2 mRNA vaccine persistence and factors associated with cardiac involvement in recently vaccinated patients
2023-09-27 19:15:11 EST Source
 5. COVID19 A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes
2023-09-25 17:57:42 EST Source
 6. COVID19 Distinguishing features of Long COVID identified through immune profiling
2023-09-25 13:21:06 EST Source
 7. COVID19 Bone marrow alterations in COVID-19 infection: The root of hematological problems
2023-09-23 20:04:29 EST Source
 8. COVID19 How do they know "no reason you can't" if no research: "there have not yet been formal studies into co-administering the RSV vaccine with either the flu or COVID vaccines. That said, there should be no reason why you can’t get the RSV vaccine at the same time as the COVID vaccine."
2023-09-23 14:16:52 EST Source
 9. COVID19 Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study
2023-09-22 20:39:35 EST Source
 10. COVID19 Severe acute respiratory syndrome coronavirus 2 infection leads to Tau pathological signature in neurons
2023-09-22 19:34:47 EST Source
 11. COVID19 Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection
2023-09-22 13:39:33 EST Source
 12. COVID19 Covid 'stay at home' warning issued after new strain detected in Britain
2023-09-22 11:06:11 EST Source
 13. COVID19 SARS-CoV-2 variants evolve convergent strategies to remodel the host response
2023-09-21 14:55:28 EST Source
 14. COVID19 Ongoing symptoms and functional impairment 12 weeks after testing positive for SARS-CoV-2 or influenza in Australia: an observational cohort study
2023-09-21 05:23:16 EST Source
 15. COVID19 “Postvaccination myocarditis has been found to be equivalent to or exceed the risk of post-COVID myocarditis in males less than 40 years old…”
2023-09-20 12:34:47 EST Source
 16. COVID19 Association between virus variants, vaccination, previous infections, and post-COVID-19 risk
2023-09-20 12:04:25 EST Source
 17. COVID19 Multisystem Inflammatory Syndrome in Children Among Persons Who Completed a Two-dose COVID-19 Vaccine Primary Series Compared With Those Reporting No COVID-19 Vaccination, US National MIS-C Surveillance
2023-09-20 04:55:33 EST Source
 18. COVID19 Patient-reported reactogenicity and safety of COVID-19 vaccinations vs. comparator vaccinations: a comparative observational cohort study
2023-09-20 04:43:03 EST Source
 19. COVID19 Biodistribution of mRNA COVID-19 vaccines in human breast milk
2023-09-19 20:56:25 EST Source
 20. COVID19 A highly divergent SARS-CoV-2 lineage B.1.1 sample in a patient with long-term COVID-19
2023-09-19 15:41:01 EST Source
 21. COVID19 Brain Pathology in COVID-19: Clinical Manifestations and Potential Mechanisms
2023-09-18 22:59:23 EST Source
 22. COVID19 Comparative study showed that children faced a 78% higher risk of new-onset conditions after they had COVID-19
2023-09-18 17:19:25 EST Source
 23. COVID19 Omega-3 polyunsaturated fatty acids and the psychiatric post-acute sequelae of COVID-19: A one-year retrospective cohort analysis of 33,908 patients
2023-09-18 02:17:08 EST Source
 24. COVID19 Genetic tracing of market wildlife and viruses at the epicenter of the COVID-19 pandemic
2023-09-17 20:20:53 EST Source
 25. COVID19 Concurrent administration of COVID-19 and influenza vaccines enhances Spike-specific antibody responses
2023-09-17 14:07:20 EST Source
 26. COVID19 SARS-CoV-2 sublingual vaccine with RBD antigen and poly(I:C) adjuvant: Preclinical study in cynomolgus macaques | Biology Methods and Protocols
2023-09-16 19:32:10 EST Source
 27. COVID19 Proximal immune-epithelial progenitor interactions drive chronic tissue sequelae post COVID-19
2023-09-16 13:06:06 EST Source
 28. COVID19 Receipt of BNT162b2 Vaccine and COVID-19 Ambulatory Visits in US Children Younger Than 5 Years
2023-09-16 10:37:16 EST Source
 29. COVID19 Receipt of BNT162b2 Vaccine and COVID-19 Ambulatory Visits in Young US Children
2023-09-16 09:23:29 EST Source
 30. COVID19 Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial
2023-09-15 13:19:24 EST Source
 31. COVID19 Immune Evasion, Infectivity, and Fusogenicity of SARS-CoV-2 Omicron BA.2.86 and FLip Variants
2023-09-14 14:14:45 EST Source
 32. COVID19 new covid shots in us.
2023-09-13 16:27:24 EST Source
 33. COVID19 The gray swan: model-based assessment of the risk of sudden failure of hybrid immunity to SARS-CoV-2
2023-09-13 16:04:46 EST Source
 34. COVID19 Whistleblower alleges CIA bribery in COVID-19 origin probe; agency denies
2023-09-13 10:23:59 EST Source
 35. COVID19 Digital holo-tomographic 3D maps of COVID-19 microclots in blood to assess disease severity
2023-09-13 03:44:17 EST Source
 36. COVID19 Relations of behavioral inhibition and activation system sensitivities with vaccination outcomes: Investigating the mediating role of vaccine hesitancy in older adults
2023-09-12 13:42:35 EST Source
 37. COVID19 Comparison of semen parameters in the same patients before and after diagnosis of COVID-19
2023-09-12 13:09:28 EST Source
 38. COVID19 SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of Immunodeficiency
2023-09-10 18:37:33 EST Source
 39. COVID19 What is the scientific rationale in not continuing to mass vaccinate?
2023-09-09 13:59:43 EST Source
 40. COVID19 Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant
2023-09-09 10:20:43 EST Source
 41. COVID19 Transmissibility, infectivity, and immune resistance of the SARS-CoV-2 BA.2.86 variant
2023-09-08 00:50:16 EST Source
 42. COVID19 First cases of SARS-CoV-2 BA.2.86 in Denmark, 2023
2023-09-07 15:10:00 EST Source
 43. COVID19 Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases
2023-09-07 10:48:06 EST Source
 44. COVID19 Forensic Analysis of the 38 Subject Deaths in the 6-Month Interim Report of the Pfizer/BioNTech BNT162b2 mRNA Vaccine Clinical Trial
2023-09-06 19:31:16 EST Source
 45. COVID19 Moderna Clinical Trial Data Confirm Its Updated Covid-19 Vaccine Generates Strong Immune Response in Humans Against BA.2.86
2023-09-06 18:28:56 EST Source
 46. COVID19 Long COVID Prevalence and the Impact of the Third SARS-CoV-2 Vaccine Dose: A Cross-Sectional Analysis from the Third Follow-Up of the Borriana Cohort, Valencia, Spain (2020-2022)
2023-09-05 23:30:46 EST Source
 47. COVID19 Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.2.86
2023-09-05 20:34:04 EST Source
 48. COVID19 Antigenicity and infectivity characterization of SARS-CoV-2 BA.2.86
2023-09-04 22:04:12 EST Source
 49. COVID19 Sensitivity of BA.2.86 to prevailing neutralising antibody responses
2023-09-04 21:32:18 EST Source
 50. COVID19 SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)
2023-09-04 13:03:19 EST Source
 51. COVID19 XBB.1.5 Spike Protein COVID-19 Vaccine Induces Broadly Neutralizing and Cellular Immune Responses Against EG.5.1 and Emerging XBB Variants
2023-09-03 19:27:24 EST Source
 52. COVID19 Long COVID Complicated by Fatal Cytomegalovirus and Aspergillus Infection of the Lungs: An Autopsy Case Report
2023-09-03 10:18:20 EST Source
 53. COVID19 Characterization of an EG.5.1 clinical isolate in vitro and in vivo
2023-09-02 01:11:34 EST Source
 54. COVID19 Convergent evolution of SARS-CoV-2 XBB lineages on receptor-binding domain 455-456 enhances antibody evasion and ACE2 binding
2023-09-01 13:52:23 EST Source
 55. COVID19 Monthly Scientific Discussion Thread - September 2023
2023-09-01 08:02:02 EST Source
 56. COVID19 Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization
2023-09-01 00:26:25 EST Source
 57. COVID19 Detection of recombinant Spike protein in the blood of individuals vaccinated against SARS-CoV-2: Possible molecular mechanisms
2023-08-31 20:21:45 EST Source
 58. COVID19 Immune Evasion and Membrane Fusion of SARS-CoV-2 XBB Subvariants EG.5.1 and XBB.2.3
2023-08-31 10:08:41 EST Source
 59. COVID19 'Spikeopathy': COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
2023-08-31 08:55:51 EST Source
 60. COVID19 Long COVID in low-income and middle-income countries: the hidden public health crisis
2023-08-30 14:56:07 EST Source
 61. COVID19 BNT162b2 COVID-19 vaccination in children alters cytokine responses to heterologous pathogens and Toll-like receptor agonists
2023-08-29 19:05:02 EST Source
 62. COVID19 SARS-CoV-2 shedding and evolution in immunocompromised hosts during the Omicron period: a multicenter prospective analysis
2023-08-28 19:10:32 EST Source
 63. COVID19 ‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
2023-08-28 06:35:23 EST Source
 64. COVID19 Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography
2023-08-28 06:00:40 EST Source
 65. COVID19 Measuring the quantity of harmful volatile organic compounds inhaled through masks
2023-08-27 21:54:06 EST Source
 66. COVID19 Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population
2023-08-27 17:57:21 EST Source
 67. COVID19 Safety and Immunogenicity of XBB.1.5-Containing mRNA Vaccines
2023-08-27 12:46:18 EST Source
 68. COVID19 Mucosal antibody responses to SARS-CoV-2 booster vaccination and breakthrough infection
2023-08-27 00:26:36 EST Source
 69. COVID19 Excess All-Cause Mortality in China After Ending the Zero COVID Policy
2023-08-26 11:00:21 EST Source
 70. COVID19 Meditation-induced bloodborne factors as an adjuvant treatment to COVID-19 disease
2023-08-26 02:54:44 EST Source
 71. COVID19 A friend of mine sent me this study. - Meditation-induced bloodborne factors as an adjuvant treatment to COVID-19 disease - I am skeptical about the sample size and the lack of diversification in the sample and survey group. Wanted to ask you guys what you think about it.
2023-08-25 15:52:00 EST Source
 72. COVID19 Report: COVID Pushed 68M Asians into Extreme Poverty
2023-08-25 12:39:25 EST Source
 73. COVID19 Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history
2023-08-24 23:43:20 EST Source
 74. COVID19 2m extra deaths recorded in China after zero Covid ended
2023-08-24 20:04:08 EST Source
 75. COVID19 Is the Vaccine-Only Strategy Sustainable?
2023-08-24 15:59:58 EST Source
 76. COVID19 Scientists traced the evolution of the coronavirus from the Wuhan variant to Omicron and found that most of the genomic mutations of SARS-CoV-2 occur due to processes in the guts and lungs. It is in these organs that the virus learns to evade the blocking microRNA molecules.
2023-08-24 05:00:36 EST Source
 77. COVID19 COVID-19: examining the effectiveness of non-pharmaceutical interventions
2023-08-23 21:25:36 EST Source
 78. COVID19 Acquired Immune Deficiency Syndrome correlation with SARS-CoV-2 N genotypes
2023-08-23 19:56:09 EST Source
 79. COVID19 about those masks....
2023-08-23 09:24:13 EST Source
 80. COVID19 Lessons From the COVID-19 Pandemic: Updating Our Approach to Masking in Health Care Facilities
2023-08-22 12:23:10 EST Source
 81. COVID19 Real-world effectiveness of molnupiravir and nirmatrelvir/ritonavir as treatments for COVID-19 in high-risk patients
2023-08-22 04:11:00 EST Source
 82. COVID19 Postacute sequelae of COVID-19 at 2 years
2023-08-21 13:07:28 EST Source
 83. COVID19 Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months–5 Years — VISION Network, United States, July 2022–June 2023
2023-08-20 16:25:48 EST Source
 84. COVID19 Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin®)
2023-08-20 10:49:29 EST Source
 85. COVID19 Pathophysiology, diagnosis, and management of neuroinflammation in covid-19
2023-08-20 10:17:46 EST Source
 86. COVID19 SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial
2023-08-19 09:33:36 EST Source
 87. COVID19 Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin®) - npj Vaccines
2023-08-18 20:24:09 EST Source
 88. COVID19 Risk assessment for SARS-CoV-2 variant V-23AUG-01 (or BA.2.86)
2023-08-18 16:32:16 EST Source
 89. COVID19 SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid models
2023-08-17 18:58:10 EST Source
 90. COVID19 Risk of autoimmune diseases following COVID-19 and the potential protective effect from vaccination: a population-based cohort study
2023-08-16 19:30:10 EST Source
 91. COVID19 COVID-19 Excess Deaths in Peru’s 25 States in 2020: Nationwide Trends, Confounding Factors, and Correlations With the Extent of Ivermectin Treatment by State
2023-08-16 15:06:04 EST Source
 92. COVID19 Exposure to lung-migrating helminth protects against murine SARS-CoV-2 infection through macrophage-dependent T cell activation
2023-08-16 13:04:56 EST Source
 93. COVID19 A possible cause of long covid fatigue and brain fog: excess WASF3 protein
2023-08-16 04:35:49 EST Source
 94. COVID19 Communication of COVID-19 Misinformation on Social Media by Physicians in the US
2023-08-15 13:12:49 EST Source
 95. COVID19 SARS-CoV-2 Neutralizing Antibodies Following a Second BA.5 Bivalent Booster
2023-08-14 21:29:05 EST Source
 96. COVID19 Yeni COVID 19 mutantı dünyaya yayılıyor
2023-08-14 09:20:56 EST Source

© Copyright hackingthevirus.com 2022-2023 Release Version 1.11162020

Return to top ►

© Copyright hackingai.app 2022-2023 Release Version 1.01202023
Return to top ►